Top 10 Healthcare AI Deals Hit $3.43B in Q2 2026, Led by Drug Discovery
HealthcareAIGuy · x · 2026-08-04
The 10 largest global healthcare AI deals of Q2 2026 totaled $3.43 billion. Drug discovery took the top spots, with Isomorphic Labs raising $2.1B Series B and Chai Discovery securing $400M Series C at a $3.8B valuation for de novo antibody design.
The rest of the funding focused heavily on administrative, access, and chronic care efficiencies. Notable areas include clinical imaging AI (Aidoc), automated scheduling and billing (Assort Health, ETERNO), supervised AI agents for chronic care (Cadence), and platforms steering patients to top-performing doctors (Garner Health).
More from Venture
- Seed Deal Volume Drops 40%: AI Tool Matches Founders with 20 Best-Fit VCs — MartinGTobias · 2026-08-04
- Anaconda Acquires Enkrypt AI to Strengthen Enterprise AI Security — anacondainc · 2026-08-04
- HappyRobot Raises $150M Series C at $1.2B Valuation to Scale Enterprise AI Agents — ycombinator · 2026-08-04
- 7-Month-Old Volta Raises $3B at $2.4B, Lands $10B Anthropic Deal — matt_slotnick · 2026-08-04
- Nscale Pledges $1M Compute to Oxford, UCL, and Imperial College — _rockt · 2026-08-04
- Amazon Accidentally Spent $1.8M Using Claude for Coding, 860% Over Budget — rvp · 2026-08-04